Drug intelligence / Profile preview

Corvite FE

Development stage: Unknown
Lead developer: Vertical Pharmaceuticals
Administration: Oral

Overview

Corvite FE is a dietary supplement developed by Vertical Pharmaceuticals, primarily indicated for the treatment of iron deficiency and iron deficiency anemia. It is a combination product containing carbonyl iron, Vitamin C (ascorbic acid), Vitamin B12 (cyanocobalamin), and Folic Acid. Carbonyl iron provides a high concentration of elemental iron with a lower risk of toxicity compared to iron salts. Vitamin C is included to enhance the gastrointestinal absorption of iron, while Vitamin B12 and Folic Acid support healthy red blood cell production (erythropoiesis).

Brand names: Corvite FE

Beyond the preview

Go deeper on Corvite FE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corvite FE.

Explore the full profile